A new bioinformatics approach identifies overexpression of GRB2 as a poor prognostic biomarker for prostate cancer

A subset of prostate cancer displays a poor clinical outcome. Therefore, identifying this poor prognostic subset within clinically aggressive groups (defined as a Gleason score (GS) ≧8) and developing effective treatments are essential if we are to improve prostate cancer survival. Here, we performe...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwata, Teppei, Sedukhina, Anna S., Kubota, Manabu, Oonuma, Shigeko, Maeda, Ichiro, Yoshiike, Miki, Usuba, Wataru, Minagawa, Kimino, Hames, Eleina, Meguro, Rei, Cho, Sunny, Chien, Stephen H. H., Urabe, Shiro, Pae, Sookhee, Palanisamy, Kishore, Kumai, Toshio, Yudo, Kazuo, Kikuchi, Eiji, Sato, Ko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952695/
https://www.ncbi.nlm.nih.gov/pubmed/33707553
http://dx.doi.org/10.1038/s41598-021-85086-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952695/
https://www.ncbi.nlm.nih.gov/pubmed/33707553
http://dx.doi.org/10.1038/s41598-021-85086-9

Ejemplares similares